Barclays PLC raised its holdings in shares of United States Cellular Co. (NYSE:USM – Free Report) by 10.8% in the 3rd quarter ...

StockNews.com upgraded shares of United States Cellular (NYSE:USM – Free Report) from a sell rating to a hold rating in a research note published on Saturday. Other analysts have also recently issued ...

Satellite services integrated with terrestrial cellular networks are still in their infancy, but the revenue from these is ...

SecurityWeek’s Cyber Insights 2025 examines expert opinions on the expected evolution of more than a dozen areas of ...

Shares of Lululemon Athletica Inc. ( LULU-Q +0.65% ) were higher by 0.9 per cent on Monday after it raised its ...

promises a dynamic and challenging year for businesses as key antitrust cases set new precedent, private antitrust litigation will intensify, ...

Qorvo, Inc. (QRVO), headquartered in Greensboro, North Carolina, is a leading provider of core technologies and radio ...

BofA raised the firm’s price target on Intra-Cellular (ITCI) to $118 from $100 and keeps a Buy rating on the shares after the company announced a favorable Caplyta patent settlement with Sandoz ...

RBC Capital lowered the firm’s price target on Intra-Cellular (ITCI) to $108 from $112 and keeps an Outperform rating on the shares as part of a broader research note previewing Q4 and 2025 ...

On Friday, BofA Securities analyst Jason Gerberry increased the price target on Intra-Cellular Therapies (NASDAQ:ITCI) to $118 from the previous $110, while maintaining a Buy rating for the ...

On Monday, Mizuho (NYSE:MFG) Securities updated its financial outlook for Intra-Cellular Therapies (NASDAQ:ITCI), increasing the stock's price target from $100 to $140 while maintaining an ...